1988
DOI: 10.1164/ajrccm/138.2.327
|View full text |Cite
|
Sign up to set email alerts
|

Clinical Features and History of the Destructive Lung Disease Associated with Alpha-1-Antitrypsin Deficiency of Adults with Pulmonary Symptoms

Abstract: Alpha-1-antitrypsin (alpha 1AT) deficiency is a hereditary disorder characterized in adults by a high risk for the development of severe destructive lung disease at an early age. The present study was designed to draw conclusions concerning the characteristics of a referral population of 124 patients with alpha 1AT deficiency and symptomatic emphysema. Typically, the alpha 1AT level was 30 mg/dl, and the alpha 1AT phenotype was almost always PiZZ. The individuals in this population were most often male, caucas… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

5
153
0
12

Year Published

1994
1994
2010
2010

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 292 publications
(170 citation statements)
references
References 20 publications
5
153
0
12
Order By: Relevance
“…For treatment of CF airway disease, delivery of a normal copy of the CF transmembrane conductance regulator gene to the defective airway epithelium should restore normal airway function (2). Likewise, for AAT deficiency, secretion of AAT from the gene-corrected airway epithelium should alleviate the development of emphysema (3).…”
Section: Microbiologymentioning
confidence: 99%
“…For treatment of CF airway disease, delivery of a normal copy of the CF transmembrane conductance regulator gene to the defective airway epithelium should restore normal airway function (2). Likewise, for AAT deficiency, secretion of AAT from the gene-corrected airway epithelium should alleviate the development of emphysema (3).…”
Section: Microbiologymentioning
confidence: 99%
“…6,7 α1AT deficiency in combination with cigarette smoking is associated with a significantly reduced life expectancy. 8,9 In addition to this pulmonary disease which is usually not clinically manifest until the third decade of life a minority of the α1AT-deficient individuals develop symptoms and signs of liver disease during childhood, ranging from transient cholostatic icterus to complete liver cirrhosis. [10][11][12] A wide spectrum of mutations in the α1AT gene has been described 7,13 and many of them are associated with severe α1AT deficiency and COPD.…”
Section: Introductionmentioning
confidence: 99%
“…Subjects with severe a 1 AT deficiency (PiZ phenotype; serum a 1 AT concentration <11 mM, likely to be 22 homocygotes) have decreased (~15±20% normal) circulating [18], and alveolar [17] concentrations of a 1 AT, which facilitates the development of early onset and rapidly progressive emphysema [19]. Around 30±40% [19] of patients also have chronic bronchitis [20], although the nature of the inflammation in the larger airways has not been studied in these individuals.…”
mentioning
confidence: 99%
“…Around 30±40% [19] of patients also have chronic bronchitis [20], although the nature of the inflammation in the larger airways has not been studied in these individuals.…”
mentioning
confidence: 99%